Functional Analysis of the Antimitogenic Activity of Tumor Suppressors

  • Erik S. Knudsen
  • Steven P. Angus
Part of the Methods in Molecular Biology™ book series (MIMB, volume 218)

Abstract

Loss of tumor suppressors contributes to numerous cancer types. Many, but not all, proteins encoded by tumor suppressor genes have antiproliferative activity and halt cell-cycle progression. In this chapter, we present three methods that have been utilized to monitor the antimitogenic action exerted by tumor suppressors. Tumor suppressor function can be demonstrated by colony formation assays and acquisition of the flat-cell phenotype. Because of the antiproliferative action of these agents, we also present two transient assays that monitor the effect of tumor suppressors on cell-cycle progression. One is based on BrdU incorporation (i.e., DNA replication) and the other on flow cytometry. Together, this triad of techniques is sufficient to determine the action of tumor suppressors and other antiproliferative agents.

Key Words

Tumor suppressor green fluorescent protein bromo-deoxy-uridine retinoblastoma cell cycle cyclin flow cytometry mitogen fluorescence microscopy 

References

  1. 1.
    Knudson, A. G. (1993) Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90, 10,914–10,921.PubMedCrossRefGoogle Scholar
  2. 2.
    Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Macleod, K. (2000) Tumor suppressor genes. Curr. Opin. Genet. Dev. 10, 81–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., et al. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305, 779–784.PubMedCrossRefGoogle Scholar
  5. 5.
    Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643–646.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y., and Lee, E. Y. (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394–1329.PubMedCrossRefGoogle Scholar
  7. 7.
    Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672–1677.PubMedCrossRefGoogle Scholar
  8. 8.
    Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57–70.PubMedCrossRefGoogle Scholar
  9. 9.
    Evan, G. I. and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348.PubMedCrossRefGoogle Scholar
  10. 10.
    Peltomaki, P. (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. 10, 735–740.PubMedCrossRefGoogle Scholar
  11. 11.
    Kolodner, R. D. (1995) Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20, 397–401.PubMedCrossRefGoogle Scholar
  12. 12.
    Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159–170.PubMedCrossRefGoogle Scholar
  13. 13.
    Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323–331.PubMedCrossRefGoogle Scholar
  14. 14.
    Wang, J. Y., Knudsen, E. S., and Welch, P. J. (1994) The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64, 25–85.PubMedCrossRefGoogle Scholar
  15. 15.
    Arap, W., Knudsen, E., Sewell, D. A., Sidransky, D., Wang, J. Y., Huang, H. J., and Cavenee, W. K. (1997) Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway. Oncogene 15, 2013–2020.PubMedCrossRefGoogle Scholar
  16. 16.
    Arap, W., Knudsen, E. S., Wang, J. Y., Cavenee, W. K., and Huang, H. J. (1997) Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma. Oncogene 14, 603–609.PubMedCrossRefGoogle Scholar
  17. 17.
    Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993–1006.PubMedCrossRefGoogle Scholar
  18. 18.
    Templeton, D. J., Park, S. H., Lanier, L., and Weinberg, R. A. (1991) Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88, 3033–3037.PubMedCrossRefGoogle Scholar
  19. 19.
    Knudsen, K. E., Weber, E., Arden, K. C., Cavenee, W. K., Feramisco, J. R., and Knudsen, E. S. (1999) The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene 18, 5239–45.PubMedCrossRefGoogle Scholar
  20. 20.
    Qin, X. Q., Chittenden, T., Livingston, D. M., and Kaelin, W. G. Jr. (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953–964.PubMedCrossRefGoogle Scholar
  21. 21.
    Knudsen, E. S., Pazzagli, C., Born, T. L., Bertolaet, B. L., Knudsen, K. E., Arden, K. C., et al. (1998) Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD. Cancer Res. 58, 2042–2049.PubMedGoogle Scholar
  22. 22.
    Knudsen, E. S., Buckmaster, C., Chen, T. T., Feramisco, J. R., and Wang, J. Y. (1998) Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev. 12, 2278–2292.PubMedCrossRefGoogle Scholar
  23. 23.
    Knudsen, K. E., Fribourg, A. F., Strobeck, M. W., Blanchard, J. M., and Knudsen, E. S. (1999) Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest. J. Biol. Chem. 274, 27,632–27,641.PubMedCrossRefGoogle Scholar
  24. 24.
    Agami, R. and Bernards, R. (2000) Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55–66.PubMedCrossRefGoogle Scholar
  25. 25.
    Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., et al. (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111–1125.PubMedCrossRefGoogle Scholar
  26. 26.
    Kanda, T., Sullivan, K. F., and Wahl, G. M. (1998) Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8, 377–385.PubMedCrossRefGoogle Scholar
  27. 27.
    Morgenstern, J. P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587–3596.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2003

Authors and Affiliations

  • Erik S. Knudsen
    • 1
  • Steven P. Angus
    • 1
  1. 1.Department of Cell Biology, Vontz Center for Molecular StudiesUniversity of Cincinnati College of MedicineCincinnati

Personalised recommendations